Clinical Trial Update: Efficacy and Safety of Dapagliflozin in Acute Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial update reports on the efficacy and safety of dapagliflozin in acute heart failure (completely enrolled and results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Heart Failure, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2024-03-15